Albani, A.
Ferraù, F. http://orcid.org/0000-0002-7472-6598
Ciresi, A.
Pivonello, R.
Scaroni, C.
Iacuaniello, D.
Zilio, M.
Guarnotta, V.
Alibrandi, A.
Messina, E.
Boscaro, M.
Giordano, C.
Colao, A.
Cannavo, S.
Article History
Received: 25 August 2017
Accepted: 9 January 2018
First Online: 30 January 2018
Compliance with ethical standards
:
: R.P. and A.C. received unrestricted grants from Novartis; A.C. is a member of the international board for clinical trials of pasireotide in acromegaly patients; C.G. received scientific grants from Novartis and served in medical advisory boards of Novartis; S.C. received grants from Novartis and served in medical advisory boards of Novartis. The remaining authors declare that they have no conflict of interest.